Literature DB >> 20019326

Noggin protects against ischemic brain injury in rodents.

Jayshree Samanta1, Tord Alden, Kevin Gobeske, Lixin Kan, John A Kessler.   

Abstract

BACKGROUND AND
PURPOSE: Bone morphogenetic proteins and their receptors are expressed in adult brains, and their expression levels increase after cerebral ischemia. The brain also expresses an inhibitor of bone morphogenetic protein signaling, noggin, but the role of noggin in ischemic disease outcome has not been studied.
METHODS: We used transgenic mice overexpressing noggin to assess whether inhibition of bone morphogenetic protein signaling affects ischemic injury responses after permanent middle cerebral artery occlusion.
RESULTS: Transgenic mice overexpressing noggin mice had significantly smaller infarct volumes and lower motor deficits compared to wild-type mice. CD11b(+) and IBA1(+) microglia along with oligodendroglial progenitors were significantly increased in transgenic mice overexpressing noggin mice at 14 days after permanent middle cerebral artery occlusion.
CONCLUSIONS: These results provide genetic evidence that overexpression of noggin reduces ischemic brain injury after permanent middle cerebral artery occlusion via enhanced activation of microglia and oligodendrogenesis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20019326      PMCID: PMC2822348          DOI: 10.1161/STROKEAHA.109.565523

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  34 in total

1.  9-Cis-retinoic acid reduces ischemic brain injury in rodents via bone morphogenetic protein.

Authors:  Hui Shen; Yu Luo; Chi-Chung Kuo; Xiaolin Deng; Chen-Fu Chang; Brandon K Harvey; Barry J Hoffer; Yun Wang
Journal:  J Neurosci Res       Date:  2009-02       Impact factor: 4.164

2.  Distribution of bone morphogenetic protein and bone morphogenetic protein receptor transcripts in the rodent nervous system and up-regulation of bone morphogenetic protein receptor type II in hippocampal dentate gyrus in a rat model of global cerebral ischemia.

Authors:  D A Charytoniuk; E Traiffort; E Pinard; O Issertial; J Seylaz; M Ruat
Journal:  Neuroscience       Date:  2000       Impact factor: 3.590

3.  Effects of lipopolysaccharide priming on acute ischemic brain injury.

Authors:  S H Ahmed; Y Y He; A Nassief; J Xu; X M Xu; C Y Hsu; F M Faraci
Journal:  Stroke       Date:  2000-01       Impact factor: 7.914

4.  Bone morphogenetic protein-6 reduces ischemia-induced brain damage in rats.

Authors:  Y Wang; C F Chang; M Morales; J Chou; H L Chen; Y H Chiang; S Z Lin; J L Cadet; X Deng; J Y Wang; S Y Chen; P L Kaplan; B J Hoffer
Journal:  Stroke       Date:  2001-09       Impact factor: 7.914

5.  Transgenic overexpression of BMP4 increases astroglial and decreases oligodendroglial lineage commitment.

Authors:  William A Gomes; Mark F Mehler; John A Kessler
Journal:  Dev Biol       Date:  2003-03-01       Impact factor: 3.582

6.  Bone morphogenetic proteins are involved in fetal kidney tissue transplantation-induced neuroprotection in stroke rats.

Authors:  C F Chang; M Morales; J Chou; H L Chen; B Hoffer; Y Wang
Journal:  Neuropharmacology       Date:  2002-09       Impact factor: 5.250

7.  Intravenous administration of bone morphogenetic protein-7 after ischemia improves motor function in stroke rats.

Authors:  Chen-Fu Chang; Shinn-Zong Lin; Yung-Hsiao Chiang; Marisela Morales; Jenny Chou; Pamela Lein; Hui-Ling Chen; Barry J Hoffer; Yun Wang
Journal:  Stroke       Date:  2003-02       Impact factor: 7.914

8.  Intracerebroventricular injection of microglia protects against focal brain ischemia.

Authors:  Yoshihisa Kitamura; Kazuyuki Takata; Masatoshi Inden; Daiju Tsuchiya; Daijiro Yanagisawa; Junko Nakata; Takashi Taniguchi
Journal:  J Pharmacol Sci       Date:  2004-02       Impact factor: 3.337

9.  IGF-I and microglia/macrophage proliferation in the ischemic mouse brain.

Authors:  Steven L O'Donnell; Terra J Frederick; J Kyle Krady; Susan J Vannucci; Teresa L Wood
Journal:  Glia       Date:  2002-07       Impact factor: 7.452

10.  IGF-I instructs multipotent adult neural progenitor cells to become oligodendrocytes.

Authors:  Jenny Hsieh; James B Aimone; Brian K Kaspar; Tomoko Kuwabara; Kinichi Nakashima; Fred H Gage
Journal:  J Cell Biol       Date:  2004-01-05       Impact factor: 10.539

View more
  21 in total

Review 1.  Regulation of microglial activation in stroke.

Authors:  Shou-Cai Zhao; Ling-Song Ma; Zhao-Hu Chu; Heng Xu; Wen-Qian Wu; Fudong Liu
Journal:  Acta Pharmacol Sin       Date:  2017-03-06       Impact factor: 6.150

2.  Bone morphogenetic protein inhibition promotes neurological recovery after intraventricular hemorrhage.

Authors:  Krishna Dummula; Govindaiah Vinukonda; Philip Chu; Yiping Xing; Furong Hu; Sabrina Mailk; Anna Csiszar; Caroline Chua; Peter Mouton; Robert J Kayton; Joshua C Brumberg; Rashmi Bansal; Praveen Ballabh
Journal:  J Neurosci       Date:  2011-08-24       Impact factor: 6.167

3.  Inhibitors of Myelination and Remyelination, Bone Morphogenetic Proteins, are Upregulated in Human Neurological Disease.

Authors:  Judith B Grinspan
Journal:  Neurochem Res       Date:  2020-02-06       Impact factor: 3.996

4.  Different temporal patterns in the expressions of bone morphogenetic proteins and noggin during astroglial scar formation after ischemic stroke.

Authors:  Jin A Shin; Jihee Lee Kang; Kyung-Eun Lee; Eun-Mi Park
Journal:  Cell Mol Neurobiol       Date:  2012-05       Impact factor: 5.046

5.  The bone morphogenetic protein antagonist noggin protects white matter after perinatal hypoxia-ischemia.

Authors:  Maria L V Dizon; Tensing Maa; John A Kessler
Journal:  Neurobiol Dis       Date:  2011-02-17       Impact factor: 5.996

Review 6.  Pharmacological approaches to intervention in hypomyelinating and demyelinating white matter pathology.

Authors:  Li-Jin Chew; Cynthia A DeBoy
Journal:  Neuropharmacology       Date:  2015-06-24       Impact factor: 5.250

7.  Agenesis of the corpus callosum in Nogo receptor deficient mice.

Authors:  Seung-Wan Yoo; Mary G Motari; Ronald L Schnaar
Journal:  J Comp Neurol       Date:  2016-07-08       Impact factor: 3.215

Review 8.  Cell-based therapy for ischemic stroke.

Authors:  Jing Zhang; Michael Chopp
Journal:  Expert Opin Biol Ther       Date:  2013-06-06       Impact factor: 4.388

9.  Olig1 is required for noggin-induced neonatal myelin repair.

Authors:  Jennifer K Sabo; Vivi Heine; John C Silbereis; Lucas Schirmer; Steven W Levison; David H Rowitch
Journal:  Ann Neurol       Date:  2017-04       Impact factor: 10.422

10.  Specific Blockade of Bone Morphogenetic Protein-2/4 Induces Oligodendrogenesis and Remyelination in Demyelinating Disorders.

Authors:  Karin Mausner-Fainberg; Moshe Benhamou; Maya Golan; Nadav Bleich Kimelman; Uri Danon; Ehud Marom; Arnon Karni
Journal:  Neurotherapeutics       Date:  2021-06-22       Impact factor: 6.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.